A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer-Reference-Cited by-同舟云学术

A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer

Published:1996-12 Issue: Volume: Page:1934-1940
ISSN:0022-5347
Container-title:The Journal of Urology
language:en
Short-container-title:The Journal of Urology

Author:

Pawinski A.,Sylvester R.,Kurth K. H.,Bouffioux C.,Van Der Meijden A.,Parmar M. K. B.,Bijnens L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference12 articles.

1. Cancer in the European community and its member states

2. Does Intravesical Chemotherapy Prevent Invasive Bladder Cancer?

3. Prophylactic Chemotherapy of Superficial Transitional Cell Bladder Carcinoma: an EORTC Randomized Trial Comparing Thiotepa, an Epipodophyllotoxin (VM26) and TUR Alone

4. Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)

5. Beta blockade during and after myocardial infarction: An overview of the randomized trials

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROGRESSION & RECURRENCE OF SUPERFICIAL BLADDER CANCER: A SINGLE-CENTER STUDY;INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH;2021-06-01

2. The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives;BJU International;2005-12

3. Correct answers to multiple choice questions appearing in the European Urology Update Series 2005;BJU International;2005-12

4. Is intravesical chemotherapy for superficial bladder cancer still justified?;BJU International;2005-10

5. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer;International Journal of Urology;2005-05